Global Biologic Medications for Psoriasis Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Biologic medications for psoriasis are advanced therapeutic agents derived from living organisms that specifically target and modulate the immune system's activity involved in the disease.These medications are typically used for moderate to severe psoriasis and are administered through injections or infusions.
The global Biologic Medications for Psoriasis market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Biologic Medications for Psoriasis Industry Forecast” looks at past sales and reviews total world Biologic Medications for Psoriasis sales in 2023, providing a comprehensive analysis by region and market sector of projected Biologic Medications for Psoriasis sales for 2024 through 2030. With Biologic Medications for Psoriasis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biologic Medications for Psoriasis industry.
This Insight Report provides a comprehensive analysis of the global Biologic Medications for Psoriasis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biologic Medications for Psoriasis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biologic Medications for Psoriasis market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biologic Medications for Psoriasis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biologic Medications for Psoriasis.
United States market for Biologic Medications for Psoriasis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Biologic Medications for Psoriasis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Biologic Medications for Psoriasis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Biologic Medications for Psoriasis players cover Bristol-Myers Squibb, Amgen, Tiefenbacher Pharmaceuticals, UCB, Janssen Biotech, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Biologic Medications for Psoriasis market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Biologic Medications for Psoriasis market?
What factors are driving Biologic Medications for Psoriasis market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Biologic Medications for Psoriasis market opportunities vary by end market size?
How does Biologic Medications for Psoriasis break out by Type, by Application?
Biologic medications for psoriasis are advanced therapeutic agents derived from living organisms that specifically target and modulate the immune system's activity involved in the disease.These medications are typically used for moderate to severe psoriasis and are administered through injections or infusions.
The global Biologic Medications for Psoriasis market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Biologic Medications for Psoriasis Industry Forecast” looks at past sales and reviews total world Biologic Medications for Psoriasis sales in 2023, providing a comprehensive analysis by region and market sector of projected Biologic Medications for Psoriasis sales for 2024 through 2030. With Biologic Medications for Psoriasis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biologic Medications for Psoriasis industry.
This Insight Report provides a comprehensive analysis of the global Biologic Medications for Psoriasis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biologic Medications for Psoriasis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biologic Medications for Psoriasis market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biologic Medications for Psoriasis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biologic Medications for Psoriasis.
United States market for Biologic Medications for Psoriasis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Biologic Medications for Psoriasis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Biologic Medications for Psoriasis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Biologic Medications for Psoriasis players cover Bristol-Myers Squibb, Amgen, Tiefenbacher Pharmaceuticals, UCB, Janssen Biotech, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Biologic Medications for Psoriasis market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- TNF-? Inhibitors
- Interleukin Inhibitors
- Tyrosine Kinase Inhibitors
- Phosphodiesterase Inhibitors
- Other
- Hospital and Clinic
- Retail Pharmacies
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bristol-Myers Squibb
- Amgen
- Tiefenbacher Pharmaceuticals
- UCB
- Janssen Biotech
- Eli Lilly
- AbbVie Biotechnology
- Dalian Yawei Pharmaceutical
- Novartis
- Ortho Dermatologics
- LEO Pharma
- Kyowa Kirin
- Boehringer Ingelheim Pharmaceuticals
- Pfizer
- Samsung Bioepis
- Qilu Pharmaceutical
- Hanwha Chemical
- China Medical System
What is the 10-year outlook for the global Biologic Medications for Psoriasis market?
What factors are driving Biologic Medications for Psoriasis market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Biologic Medications for Psoriasis market opportunities vary by end market size?
How does Biologic Medications for Psoriasis break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biologic Medications for Psoriasis Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Biologic Medications for Psoriasis by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Biologic Medications for Psoriasis by Country/Region, 2019, 2023 & 2030
2.2 Biologic Medications for Psoriasis Segment by Type
2.2.1 TNF-? Inhibitors
2.2.2 Interleukin Inhibitors
2.2.3 Tyrosine Kinase Inhibitors
2.2.4 Phosphodiesterase Inhibitors
2.2.5 Other
2.3 Biologic Medications for Psoriasis Sales by Type
2.3.1 Global Biologic Medications for Psoriasis Sales Market Share by Type (2019-2024)
2.3.2 Global Biologic Medications for Psoriasis Revenue and Market Share by Type (2019-2024)
2.3.3 Global Biologic Medications for Psoriasis Sale Price by Type (2019-2024)
2.4 Biologic Medications for Psoriasis Segment by Application
2.4.1 Hospital and Clinic
2.4.2 Retail Pharmacies
2.4.3 Other
2.5 Biologic Medications for Psoriasis Sales by Application
2.5.1 Global Biologic Medications for Psoriasis Sale Market Share by Application (2019-2024)
2.5.2 Global Biologic Medications for Psoriasis Revenue and Market Share by Application (2019-2024)
2.5.3 Global Biologic Medications for Psoriasis Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Biologic Medications for Psoriasis Breakdown Data by Company
3.1.1 Global Biologic Medications for Psoriasis Annual Sales by Company (2019-2024)
3.1.2 Global Biologic Medications for Psoriasis Sales Market Share by Company (2019-2024)
3.2 Global Biologic Medications for Psoriasis Annual Revenue by Company (2019-2024)
3.2.1 Global Biologic Medications for Psoriasis Revenue by Company (2019-2024)
3.2.2 Global Biologic Medications for Psoriasis Revenue Market Share by Company (2019-2024)
3.3 Global Biologic Medications for Psoriasis Sale Price by Company
3.4 Key Manufacturers Biologic Medications for Psoriasis Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Biologic Medications for Psoriasis Product Location Distribution
3.4.2 Players Biologic Medications for Psoriasis Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BIOLOGIC MEDICATIONS FOR PSORIASIS BY GEOGRAPHIC REGION
4.1 World Historic Biologic Medications for Psoriasis Market Size by Geographic Region (2019-2024)
4.1.1 Global Biologic Medications for Psoriasis Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Biologic Medications for Psoriasis Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Biologic Medications for Psoriasis Market Size by Country/Region (2019-2024)
4.2.1 Global Biologic Medications for Psoriasis Annual Sales by Country/Region (2019-2024)
4.2.2 Global Biologic Medications for Psoriasis Annual Revenue by Country/Region (2019-2024)
4.3 Americas Biologic Medications for Psoriasis Sales Growth
4.4 APAC Biologic Medications for Psoriasis Sales Growth
4.5 Europe Biologic Medications for Psoriasis Sales Growth
4.6 Middle East & Africa Biologic Medications for Psoriasis Sales Growth
5 AMERICAS
5.1 Americas Biologic Medications for Psoriasis Sales by Country
5.1.1 Americas Biologic Medications for Psoriasis Sales by Country (2019-2024)
5.1.2 Americas Biologic Medications for Psoriasis Revenue by Country (2019-2024)
5.2 Americas Biologic Medications for Psoriasis Sales by Type (2019-2024)
5.3 Americas Biologic Medications for Psoriasis Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biologic Medications for Psoriasis Sales by Region
6.1.1 APAC Biologic Medications for Psoriasis Sales by Region (2019-2024)
6.1.2 APAC Biologic Medications for Psoriasis Revenue by Region (2019-2024)
6.2 APAC Biologic Medications for Psoriasis Sales by Type (2019-2024)
6.3 APAC Biologic Medications for Psoriasis Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Biologic Medications for Psoriasis by Country
7.1.1 Europe Biologic Medications for Psoriasis Sales by Country (2019-2024)
7.1.2 Europe Biologic Medications for Psoriasis Revenue by Country (2019-2024)
7.2 Europe Biologic Medications for Psoriasis Sales by Type (2019-2024)
7.3 Europe Biologic Medications for Psoriasis Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biologic Medications for Psoriasis by Country
8.1.1 Middle East & Africa Biologic Medications for Psoriasis Sales by Country (2019-2024)
8.1.2 Middle East & Africa Biologic Medications for Psoriasis Revenue by Country (2019-2024)
8.2 Middle East & Africa Biologic Medications for Psoriasis Sales by Type (2019-2024)
8.3 Middle East & Africa Biologic Medications for Psoriasis Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Biologic Medications for Psoriasis
10.3 Manufacturing Process Analysis of Biologic Medications for Psoriasis
10.4 Industry Chain Structure of Biologic Medications for Psoriasis
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Biologic Medications for Psoriasis Distributors
11.3 Biologic Medications for Psoriasis Customer
12 WORLD FORECAST REVIEW FOR BIOLOGIC MEDICATIONS FOR PSORIASIS BY GEOGRAPHIC REGION
12.1 Global Biologic Medications for Psoriasis Market Size Forecast by Region
12.1.1 Global Biologic Medications for Psoriasis Forecast by Region (2025-2030)
12.1.2 Global Biologic Medications for Psoriasis Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Biologic Medications for Psoriasis Forecast by Type (2025-2030)
12.7 Global Biologic Medications for Psoriasis Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Bristol-Myers Squibb
13.1.1 Bristol-Myers Squibb Company Information
13.1.2 Bristol-Myers Squibb Biologic Medications for Psoriasis Product Portfolios and Specifications
13.1.3 Bristol-Myers Squibb Biologic Medications for Psoriasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Bristol-Myers Squibb Main Business Overview
13.1.5 Bristol-Myers Squibb Latest Developments
13.2 Amgen
13.2.1 Amgen Company Information
13.2.2 Amgen Biologic Medications for Psoriasis Product Portfolios and Specifications
13.2.3 Amgen Biologic Medications for Psoriasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Amgen Main Business Overview
13.2.5 Amgen Latest Developments
13.3 Tiefenbacher Pharmaceuticals
13.3.1 Tiefenbacher Pharmaceuticals Company Information
13.3.2 Tiefenbacher Pharmaceuticals Biologic Medications for Psoriasis Product Portfolios and Specifications
13.3.3 Tiefenbacher Pharmaceuticals Biologic Medications for Psoriasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Tiefenbacher Pharmaceuticals Main Business Overview
13.3.5 Tiefenbacher Pharmaceuticals Latest Developments
13.4 UCB
13.4.1 UCB Company Information
13.4.2 UCB Biologic Medications for Psoriasis Product Portfolios and Specifications
13.4.3 UCB Biologic Medications for Psoriasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 UCB Main Business Overview
13.4.5 UCB Latest Developments
13.5 Janssen Biotech
13.5.1 Janssen Biotech Company Information
13.5.2 Janssen Biotech Biologic Medications for Psoriasis Product Portfolios and Specifications
13.5.3 Janssen Biotech Biologic Medications for Psoriasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Janssen Biotech Main Business Overview
13.5.5 Janssen Biotech Latest Developments
13.6 Eli Lilly
13.6.1 Eli Lilly Company Information
13.6.2 Eli Lilly Biologic Medications for Psoriasis Product Portfolios and Specifications
13.6.3 Eli Lilly Biologic Medications for Psoriasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Eli Lilly Main Business Overview
13.6.5 Eli Lilly Latest Developments
13.7 AbbVie Biotechnology
13.7.1 AbbVie Biotechnology Company Information
13.7.2 AbbVie Biotechnology Biologic Medications for Psoriasis Product Portfolios and Specifications
13.7.3 AbbVie Biotechnology Biologic Medications for Psoriasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 AbbVie Biotechnology Main Business Overview
13.7.5 AbbVie Biotechnology Latest Developments
13.8 Dalian Yawei Pharmaceutical
13.8.1 Dalian Yawei Pharmaceutical Company Information
13.8.2 Dalian Yawei Pharmaceutical Biologic Medications for Psoriasis Product Portfolios and Specifications
13.8.3 Dalian Yawei Pharmaceutical Biologic Medications for Psoriasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Dalian Yawei Pharmaceutical Main Business Overview
13.8.5 Dalian Yawei Pharmaceutical Latest Developments
13.9 Novartis
13.9.1 Novartis Company Information
13.9.2 Novartis Biologic Medications for Psoriasis Product Portfolios and Specifications
13.9.3 Novartis Biologic Medications for Psoriasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Novartis Main Business Overview
13.9.5 Novartis Latest Developments
13.10 Ortho Dermatologics
13.10.1 Ortho Dermatologics Company Information
13.10.2 Ortho Dermatologics Biologic Medications for Psoriasis Product Portfolios and Specifications
13.10.3 Ortho Dermatologics Biologic Medications for Psoriasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Ortho Dermatologics Main Business Overview
13.10.5 Ortho Dermatologics Latest Developments
13.11 LEO Pharma
13.11.1 LEO Pharma Company Information
13.11.2 LEO Pharma Biologic Medications for Psoriasis Product Portfolios and Specifications
13.11.3 LEO Pharma Biologic Medications for Psoriasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 LEO Pharma Main Business Overview
13.11.5 LEO Pharma Latest Developments
13.12 Kyowa Kirin
13.12.1 Kyowa Kirin Company Information
13.12.2 Kyowa Kirin Biologic Medications for Psoriasis Product Portfolios and Specifications
13.12.3 Kyowa Kirin Biologic Medications for Psoriasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Kyowa Kirin Main Business Overview
13.12.5 Kyowa Kirin Latest Developments
13.13 Boehringer Ingelheim Pharmaceuticals
13.13.1 Boehringer Ingelheim Pharmaceuticals Company Information
13.13.2 Boehringer Ingelheim Pharmaceuticals Biologic Medications for Psoriasis Product Portfolios and Specifications
13.13.3 Boehringer Ingelheim Pharmaceuticals Biologic Medications for Psoriasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Boehringer Ingelheim Pharmaceuticals Main Business Overview
13.13.5 Boehringer Ingelheim Pharmaceuticals Latest Developments
13.14 Pfizer
13.14.1 Pfizer Company Information
13.14.2 Pfizer Biologic Medications for Psoriasis Product Portfolios and Specifications
13.14.3 Pfizer Biologic Medications for Psoriasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Pfizer Main Business Overview
13.14.5 Pfizer Latest Developments
13.15 Samsung Bioepis
13.15.1 Samsung Bioepis Company Information
13.15.2 Samsung Bioepis Biologic Medications for Psoriasis Product Portfolios and Specifications
13.15.3 Samsung Bioepis Biologic Medications for Psoriasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Samsung Bioepis Main Business Overview
13.15.5 Samsung Bioepis Latest Developments
13.16 Qilu Pharmaceutical
13.16.1 Qilu Pharmaceutical Company Information
13.16.2 Qilu Pharmaceutical Biologic Medications for Psoriasis Product Portfolios and Specifications
13.16.3 Qilu Pharmaceutical Biologic Medications for Psoriasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Qilu Pharmaceutical Main Business Overview
13.16.5 Qilu Pharmaceutical Latest Developments
13.17 Hanwha Chemical
13.17.1 Hanwha Chemical Company Information
13.17.2 Hanwha Chemical Biologic Medications for Psoriasis Product Portfolios and Specifications
13.17.3 Hanwha Chemical Biologic Medications for Psoriasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Hanwha Chemical Main Business Overview
13.17.5 Hanwha Chemical Latest Developments
13.18 China Medical System
13.18.1 China Medical System Company Information
13.18.2 China Medical System Biologic Medications for Psoriasis Product Portfolios and Specifications
13.18.3 China Medical System Biologic Medications for Psoriasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 China Medical System Main Business Overview
13.18.5 China Medical System Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Biologic Medications for Psoriasis Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Biologic Medications for Psoriasis Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players ofTNF-? Inhibitors
Table 4. Major Players of Interleukin Inhibitors
Table 5. Major Players ofTyrosine Kinase Inhibitors
Table 6. Major Players of Phosphodiesterase Inhibitors
Table 7. Major Players of Other
Table 8. Global Biologic Medications for Psoriasis Sales byType (2019-2024) & (K Units)
Table 9. Global Biologic Medications for Psoriasis Sales Market Share byType (2019-2024)
Table 10. Global Biologic Medications for Psoriasis Revenue byType (2019-2024) & ($ million)
Table 11. Global Biologic Medications for Psoriasis Revenue Market Share byType (2019-2024)
Table 12. Global Biologic Medications for Psoriasis Sale Price byType (2019-2024) & (US$/Unit)
Table 13. Global Biologic Medications for Psoriasis Sale by Application (2019-2024) & (K Units)
Table 14. Global Biologic Medications for Psoriasis Sale Market Share by Application (2019-2024)
Table 15. Global Biologic Medications for Psoriasis Revenue by Application (2019-2024) & ($ million)
Table 16. Global Biologic Medications for Psoriasis Revenue Market Share by Application (2019-2024)
Table 17. Global Biologic Medications for Psoriasis Sale Price by Application (2019-2024) & (US$/Unit)
Table 18. Global Biologic Medications for Psoriasis Sales by Company (2019-2024) & (K Units)
Table 19. Global Biologic Medications for Psoriasis Sales Market Share by Company (2019-2024)
Table 20. Global Biologic Medications for Psoriasis Revenue by Company (2019-2024) & ($ millions)
Table 21. Global Biologic Medications for Psoriasis Revenue Market Share by Company (2019-2024)
Table 22. Global Biologic Medications for Psoriasis Sale Price by Company (2019-2024) & (US$/Unit)
Table 23. Key Manufacturers Biologic Medications for Psoriasis Producing Area Distribution and Sales Area
Table 24. Players Biologic Medications for Psoriasis Products Offered
Table 25. Biologic Medications for Psoriasis Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Biologic Medications for Psoriasis Sales by Geographic Region (2019-2024) & (K Units)
Table 29. Global Biologic Medications for Psoriasis Sales Market Share Geographic Region (2019-2024)
Table 30. Global Biologic Medications for Psoriasis Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Biologic Medications for Psoriasis Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Biologic Medications for Psoriasis Sales by Country/Region (2019-2024) & (K Units)
Table 33. Global Biologic Medications for Psoriasis Sales Market Share by Country/Region (2019-2024)
Table 34. Global Biologic Medications for Psoriasis Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Biologic Medications for Psoriasis Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Biologic Medications for Psoriasis Sales by Country (2019-2024) & (K Units)
Table 37. Americas Biologic Medications for Psoriasis Sales Market Share by Country (2019-2024)
Table 38. Americas Biologic Medications for Psoriasis Revenue by Country (2019-2024) & ($ millions)
Table 39. Americas Biologic Medications for Psoriasis Sales byType (2019-2024) & (K Units)
Table 40. Americas Biologic Medications for Psoriasis Sales by Application (2019-2024) & (K Units)
Table 41. APAC Biologic Medications for Psoriasis Sales by Region (2019-2024) & (K Units)
Table 42. APAC Biologic Medications for Psoriasis Sales Market Share by Region (2019-2024)
Table 43. APAC Biologic Medications for Psoriasis Revenue by Region (2019-2024) & ($ millions)
Table 44. APAC Biologic Medications for Psoriasis Sales byType (2019-2024) & (K Units)
Table 45. APAC Biologic Medications for Psoriasis Sales by Application (2019-2024) & (K Units)
Table 46. Europe Biologic Medications for Psoriasis Sales by Country (2019-2024) & (K Units)
Table 47. Europe Biologic Medications for Psoriasis Revenue by Country (2019-2024) & ($ millions)
Table 48. Europe Biologic Medications for Psoriasis Sales byType (2019-2024) & (K Units)
Table 49. Europe Biologic Medications for Psoriasis Sales by Application (2019-2024) & (K Units)
Table 50. Middle East & Africa Biologic Medications for Psoriasis Sales by Country (2019-2024) & (K Units)
Table 51. Middle East & Africa Biologic Medications for Psoriasis Revenue Market Share by Country (2019-2024)
Table 52. Middle East & Africa Biologic Medications for Psoriasis Sales byType (2019-2024) & (K Units)
Table 53. Middle East & Africa Biologic Medications for Psoriasis Sales by Application (2019-2024) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Biologic Medications for Psoriasis
Table 55. Key Market Challenges & Risks of Biologic Medications for Psoriasis
Table 56. Key IndustryTrends of Biologic Medications for Psoriasis
Table 57. Biologic Medications for Psoriasis Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Biologic Medications for Psoriasis Distributors List
Table 60. Biologic Medications for Psoriasis Customer List
Table 61. Global Biologic Medications for Psoriasis SalesForecast by Region (2025-2030) & (K Units)
Table 62. Global Biologic Medications for Psoriasis RevenueForecast by Region (2025-2030) & ($ millions)
Table 63. Americas Biologic Medications for Psoriasis SalesForecast by Country (2025-2030) & (K Units)
Table 64. Americas Biologic Medications for Psoriasis Annual RevenueForecast by Country (2025-2030) & ($ millions)
Table 65. APAC Biologic Medications for Psoriasis SalesForecast by Region (2025-2030) & (K Units)
Table 66. APAC Biologic Medications for Psoriasis Annual RevenueForecast by Region (2025-2030) & ($ millions)
Table 67. Europe Biologic Medications for Psoriasis SalesForecast by Country (2025-2030) & (K Units)
Table 68. Europe Biologic Medications for Psoriasis RevenueForecast by Country (2025-2030) & ($ millions)
Table 69. Middle East & Africa Biologic Medications for Psoriasis SalesForecast by Country (2025-2030) & (K Units)
Table 70. Middle East & Africa Biologic Medications for Psoriasis RevenueForecast by Country (2025-2030) & ($ millions)
Table 71. Global Biologic Medications for Psoriasis SalesForecast byType (2025-2030) & (K Units)
Table 72. Global Biologic Medications for Psoriasis RevenueForecast byType (2025-2030) & ($ millions)
Table 73. Global Biologic Medications for Psoriasis SalesForecast by Application (2025-2030) & (K Units)
Table 74. Global Biologic Medications for Psoriasis RevenueForecast by Application (2025-2030) & ($ millions)
Table 75. Bristol-Myers Squibb Basic Information, Biologic Medications for Psoriasis Manufacturing Base, Sales Area and Its Competitors
Table 76. Bristol-Myers Squibb Biologic Medications for Psoriasis Product Portfolios and Specifications
Table 77. Bristol-Myers Squibb Biologic Medications for Psoriasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Bristol-Myers Squibb Main Business
Table 79. Bristol-Myers Squibb Latest Developments
Table 80. Amgen Basic Information, Biologic Medications for Psoriasis Manufacturing Base, Sales Area and Its Competitors
Table 81. Amgen Biologic Medications for Psoriasis Product Portfolios and Specifications
Table 82. Amgen Biologic Medications for Psoriasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Amgen Main Business
Table 84. Amgen Latest Developments
Table 85.Tiefenbacher Pharmaceuticals Basic Information, Biologic Medications for Psoriasis Manufacturing Base, Sales Area and Its Competitors
Table 86.Tiefenbacher Pharmaceuticals Biologic Medications for Psoriasis Product Portfolios and Specifications
Table 87.Tiefenbacher Pharmaceuticals Biologic Medications for Psoriasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88.Tiefenbacher Pharmaceuticals Main Business
Table 89.Tiefenbacher Pharmaceuticals Latest Developments
Table 90. UCB Basic Information, Biologic Medications for Psoriasis Manufacturing Base, Sales Area and Its Competitors
Table 91. UCB Biologic Medications for Psoriasis Product Portfolios and Specifications
Table 92. UCB Biologic Medications for Psoriasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. UCB Main Business
Table 94. UCB Latest Developments
Table 95. Janssen Biotech Basic Information, Biologic Medications for Psoriasis Manufacturing Base, Sales Area and Its Competitors
Table 96. Janssen Biotech Biologic Medications for Psoriasis Product Portfolios and Specifications
Table 97. Janssen Biotech Biologic Medications for Psoriasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Janssen Biotech Main Business
Table 99. Janssen Biotech Latest Developments
Table 100. Eli Lilly Basic Information, Biologic Medications for Psoriasis Manufacturing Base, Sales Area and Its Competitors
Table 101. Eli Lilly Biologic Medications for Psoriasis Product Portfolios and Specifications
Table 102. Eli Lilly Biologic Medications for Psoriasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Eli Lilly Main Business
Table 104. Eli Lilly Latest Developments
Table 105. AbbVie Biotechnology Basic Information, Biologic Medications for Psoriasis Manufacturing Base, Sales Area and Its Competitors
Table 106. AbbVie Biotechnology Biologic Medications for Psoriasis Product Portfolios and Specifications
Table 107. AbbVie Biotechnology Biologic Medications for Psoriasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. AbbVie Biotechnology Main Business
Table 109. AbbVie Biotechnology Latest Developments
Table 110. Dalian Yawei Pharmaceutical Basic Information, Biologic Medications for Psoriasis Manufacturing Base, Sales Area and Its Competitors
Table 111. Dalian Yawei Pharmaceutical Biologic Medications for Psoriasis Product Portfolios and Specifications
Table 112. Dalian Yawei Pharmaceutical Biologic Medications for Psoriasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Dalian Yawei Pharmaceutical Main Business
Table 114. Dalian Yawei Pharmaceutical Latest Developments
Table 115. Novartis Basic Information, Biologic Medications for Psoriasis Manufacturing Base, Sales Area and Its Competitors
Table 116. Novartis Biologic Medications for Psoriasis Product Portfolios and Specifications
Table 117. Novartis Biologic Medications for Psoriasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Novartis Main Business
Table 119. Novartis Latest Developments
Table 120. Ortho Dermatologics Basic Information, Biologic Medications for Psoriasis Manufacturing Base, Sales Area and Its Competitors
Table 121. Ortho Dermatologics Biologic Medications for Psoriasis Product Portfolios and Specifications
Table 122. Ortho Dermatologics Biologic Medications for Psoriasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Ortho Dermatologics Main Business
Table 124. Ortho Dermatologics Latest Developments
Table 125. LEO Pharma Basic Information, Biologic Medications for Psoriasis Manufacturing Base, Sales Area and Its Competitors
Table 126. LEO Pharma Biologic Medications for Psoriasis Product Portfolios and Specifications
Table 127. LEO Pharma Biologic Medications for Psoriasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. LEO Pharma Main Business
Table 129. LEO Pharma Latest Developments
Table 130. Kyowa Kirin Basic Information, Biologic Medications for Psoriasis Manufacturing Base, Sales Area and Its Competitors
Table 131. Kyowa Kirin Biologic Medications for Psoriasis Product Portfolios and Specifications
Table 132. Kyowa Kirin Biologic Medications for Psoriasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Kyowa Kirin Main Business
Table 134. Kyowa Kirin Latest Developments
Table 135. Boehringer Ingelheim Pharmaceuticals Basic Information, Biologic Medications for Psoriasis Manufacturing Base, Sales Area and Its Competitors
Table 136. Boehringer Ingelheim Pharmaceuticals Biologic Medications for Psoriasis Product Portfolios and Specifications
Table 137. Boehringer Ingelheim Pharmaceuticals Biologic Medications for Psoriasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Boehringer Ingelheim Pharmaceuticals Main Business
Table 139. Boehringer Ingelheim Pharmaceuticals Latest Developments
Table 140. Pfizer Basic Information, Biologic Medications for Psoriasis Manufacturing Base, Sales Area and Its Competitors
Table 141. Pfizer Biologic Medications for Psoriasis Product Portfolios and Specifications
Table 142. Pfizer Biologic Medications for Psoriasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Pfizer Main Business
Table 144. Pfizer Latest Developments
Table 145. Samsung Bioepis Basic Information, Biologic Medications for Psoriasis Manufacturing Base, Sales Area and Its Competitors
Table 146. Samsung Bioepis Biologic Medications for Psoriasis Product Portfolios and Specifications
Table 147. Samsung Bioepis Biologic Medications for Psoriasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Samsung Bioepis Main Business
Table 149. Samsung Bioepis Latest Developments
Table 150. Qilu Pharmaceutical Basic Information, Biologic Medications for Psoriasis Manufacturing Base, Sales Area and Its Competitors
Table 151. Qilu Pharmaceutical Biologic Medications for Psoriasis Product Portfolios and Specifications
Table 152. Qilu Pharmaceutical Biologic Medications for Psoriasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Qilu Pharmaceutical Main Business
Table 154. Qilu Pharmaceutical Latest Developments
Table 155. Hanwha Chemical Basic Information, Biologic Medications for Psoriasis Manufacturing Base, Sales Area and Its Competitors
Table 156. Hanwha Chemical Biologic Medications for Psoriasis Product Portfolios and Specifications
Table 157. Hanwha Chemical Biologic Medications for Psoriasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. Hanwha Chemical Main Business
Table 159. Hanwha Chemical Latest Developments
Table 160. China Medical System Basic Information, Biologic Medications for Psoriasis Manufacturing Base, Sales Area and Its Competitors
Table 161. China Medical System Biologic Medications for Psoriasis Product Portfolios and Specifications
Table 162. China Medical System Biologic Medications for Psoriasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 163. China Medical System Main Business
Table 164. China Medical System Latest Developments
LIST OFFIGURES
Figure 1. Picture of Biologic Medications for Psoriasis
Figure 2. Biologic Medications for Psoriasis Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biologic Medications for Psoriasis Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Biologic Medications for Psoriasis Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Biologic Medications for Psoriasis Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Biologic Medications for Psoriasis Sales Market Share by Country/Region (2023)
Figure 10. Biologic Medications for Psoriasis Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture ofTNF-? Inhibitors
Figure 12. Product Picture of Interleukin Inhibitors
Figure 13. Product Picture ofTyrosine Kinase Inhibitors
Figure 14. Product Picture of Phosphodiesterase Inhibitors
Figure 15. Product Picture of Other
Figure 16. Global Biologic Medications for Psoriasis Sales Market Share byType in 2023
Figure 17. Global Biologic Medications for Psoriasis Revenue Market Share byType (2019-2024)
Figure 18. Biologic Medications for Psoriasis Consumed in Hospital and Clinic
Figure 19. Global Biologic Medications for Psoriasis Market: Hospital and Clinic (2019-2024) & (K Units)
Figure 20. Biologic Medications for Psoriasis Consumed in Retail Pharmacies
Figure 21. Global Biologic Medications for Psoriasis Market: Retail Pharmacies (2019-2024) & (K Units)
Figure 22. Biologic Medications for Psoriasis Consumed in Other
Figure 23. Global Biologic Medications for Psoriasis Market: Other (2019-2024) & (K Units)
Figure 24. Global Biologic Medications for Psoriasis Sale Market Share by Application (2023)
Figure 25. Global Biologic Medications for Psoriasis Revenue Market Share by Application in 2023
Figure 26. Biologic Medications for Psoriasis Sales by Company in 2023 (K Units)
Figure 27. Global Biologic Medications for Psoriasis Sales Market Share by Company in 2023
Figure 28. Biologic Medications for Psoriasis Revenue by Company in 2023 ($ millions)
Figure 29. Global Biologic Medications for Psoriasis Revenue Market Share by Company in 2023
Figure 30. Global Biologic Medications for Psoriasis Sales Market Share by Geographic Region (2019-2024)
Figure 31. Global Biologic Medications for Psoriasis Revenue Market Share by Geographic Region in 2023
Figure 32. Americas Biologic Medications for Psoriasis Sales 2019-2024 (K Units)
Figure 33. Americas Biologic Medications for Psoriasis Revenue 2019-2024 ($ millions)
Figure 34. APAC Biologic Medications for Psoriasis Sales 2019-2024 (K Units)
Figure 35. APAC Biologic Medications for Psoriasis Revenue 2019-2024 ($ millions)
Figure 36. Europe Biologic Medications for Psoriasis Sales 2019-2024 (K Units)
Figure 37. Europe Biologic Medications for Psoriasis Revenue 2019-2024 ($ millions)
Figure 38. Middle East & Africa Biologic Medications for Psoriasis Sales 2019-2024 (K Units)
Figure 39. Middle East & Africa Biologic Medications for Psoriasis Revenue 2019-2024 ($ millions)
Figure 40. Americas Biologic Medications for Psoriasis Sales Market Share by Country in 2023
Figure 41. Americas Biologic Medications for Psoriasis Revenue Market Share by Country (2019-2024)
Figure 42. Americas Biologic Medications for Psoriasis Sales Market Share byType (2019-2024)
Figure 43. Americas Biologic Medications for Psoriasis Sales Market Share by Application (2019-2024)
Figure 44. United States Biologic Medications for Psoriasis Revenue Growth 2019-2024 ($ millions)
Figure 45. Canada Biologic Medications for Psoriasis Revenue Growth 2019-2024 ($ millions)
Figure 46. Mexico Biologic Medications for Psoriasis Revenue Growth 2019-2024 ($ millions)
Figure 47. Brazil Biologic Medications for Psoriasis Revenue Growth 2019-2024 ($ millions)
Figure 48. APAC Biologic Medications for Psoriasis Sales Market Share by Region in 2023
Figure 49. APAC Biologic Medications for Psoriasis Revenue Market Share by Region (2019-2024)
Figure 50. APAC Biologic Medications for Psoriasis Sales Market Share byType (2019-2024)
Figure 51. APAC Biologic Medications for Psoriasis Sales Market Share by Application (2019-2024)
Figure 52. China Biologic Medications for Psoriasis Revenue Growth 2019-2024 ($ millions)
Figure 53. Japan Biologic Medications for Psoriasis Revenue Growth 2019-2024 ($ millions)
Figure 54. South Korea Biologic Medications for Psoriasis Revenue Growth 2019-2024 ($ millions)
Figure 55. Southeast Asia Biologic Medications for Psoriasis Revenue Growth 2019-2024 ($ millions)
Figure 56. India Biologic Medications for Psoriasis Revenue Growth 2019-2024 ($ millions)
Figure 57. Australia Biologic Medications for Psoriasis Revenue Growth 2019-2024 ($ millions)
Figure 58. ChinaTaiwan Biologic Medications for Psoriasis Revenue Growth 2019-2024 ($ millions)
Figure 59. Europe Biologic Medications for Psoriasis Sales Market Share by Country in 2023
Figure 60. Europe Biologic Medications for Psoriasis Revenue Market Share by Country (2019-2024)
Figure 61. Europe Biologic Medications for Psoriasis Sales Market Share byType (2019-2024)
Figure 62. Europe Biologic Medications for Psoriasis Sales Market Share by Application (2019-2024)
Figure 63. Germany Biologic Medications for Psoriasis Revenue Growth 2019-2024 ($ millions)
Figure 64.France Biologic Medications for Psoriasis Revenue Growth 2019-2024 ($ millions)
Figure 65. UK Biologic Medications for Psoriasis Revenue Growth 2019-2024 ($ millions)
Figure 66. Italy Biologic Medications for Psoriasis Revenue Growth 2019-2024 ($ millions)
Figure 67. Russia Biologic Medications for Psoriasis Revenue Growth 2019-2024 ($ millions)
Figure 68. Middle East & Africa Biologic Medications for Psoriasis Sales Market Share by Country (2019-2024)
Figure 69. Middle East & Africa Biologic Medications for Psoriasis Sales Market Share byType (2019-2024)
Figure 70. Middle East & Africa Biologic Medications for Psoriasis Sales Market Share by Application (2019-2024)
Figure 71. Egypt Biologic Medications for Psoriasis Revenue Growth 2019-2024 ($ millions)
Figure 72. South Africa Biologic Medications for Psoriasis Revenue Growth 2019-2024 ($ millions)
Figure 73. Israel Biologic Medications for Psoriasis Revenue Growth 2019-2024 ($ millions)
Figure 74.Turkey Biologic Medications for Psoriasis Revenue Growth 2019-2024 ($ millions)
Figure 75. GCC Countries Biologic Medications for Psoriasis Revenue Growth 2019-2024 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Biologic Medications for Psoriasis in 2023
Figure 77. Manufacturing Process Analysis of Biologic Medications for Psoriasis
Figure 78. Industry Chain Structure of Biologic Medications for Psoriasis
Figure 79. Channels of Distribution
Figure 80. Global Biologic Medications for Psoriasis Sales MarketForecast by Region (2025-2030)
Figure 81. Global Biologic Medications for Psoriasis Revenue Market ShareForecast by Region (2025-2030)
Figure 82. Global Biologic Medications for Psoriasis Sales Market ShareForecast byType (2025-2030)
Figure 83. Global Biologic Medications for Psoriasis Revenue Market ShareForecast byType (2025-2030)
Figure 84. Global Biologic Medications for Psoriasis Sales Market ShareForecast by Application (2025-2030)
Figure 85. Global Biologic Medications for Psoriasis Revenue Market ShareForecast by Application (2025-2030)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biologic Medications for Psoriasis Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Biologic Medications for Psoriasis by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Biologic Medications for Psoriasis by Country/Region, 2019, 2023 & 2030
2.2 Biologic Medications for Psoriasis Segment by Type
2.2.1 TNF-? Inhibitors
2.2.2 Interleukin Inhibitors
2.2.3 Tyrosine Kinase Inhibitors
2.2.4 Phosphodiesterase Inhibitors
2.2.5 Other
2.3 Biologic Medications for Psoriasis Sales by Type
2.3.1 Global Biologic Medications for Psoriasis Sales Market Share by Type (2019-2024)
2.3.2 Global Biologic Medications for Psoriasis Revenue and Market Share by Type (2019-2024)
2.3.3 Global Biologic Medications for Psoriasis Sale Price by Type (2019-2024)
2.4 Biologic Medications for Psoriasis Segment by Application
2.4.1 Hospital and Clinic
2.4.2 Retail Pharmacies
2.4.3 Other
2.5 Biologic Medications for Psoriasis Sales by Application
2.5.1 Global Biologic Medications for Psoriasis Sale Market Share by Application (2019-2024)
2.5.2 Global Biologic Medications for Psoriasis Revenue and Market Share by Application (2019-2024)
2.5.3 Global Biologic Medications for Psoriasis Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Biologic Medications for Psoriasis Breakdown Data by Company
3.1.1 Global Biologic Medications for Psoriasis Annual Sales by Company (2019-2024)
3.1.2 Global Biologic Medications for Psoriasis Sales Market Share by Company (2019-2024)
3.2 Global Biologic Medications for Psoriasis Annual Revenue by Company (2019-2024)
3.2.1 Global Biologic Medications for Psoriasis Revenue by Company (2019-2024)
3.2.2 Global Biologic Medications for Psoriasis Revenue Market Share by Company (2019-2024)
3.3 Global Biologic Medications for Psoriasis Sale Price by Company
3.4 Key Manufacturers Biologic Medications for Psoriasis Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Biologic Medications for Psoriasis Product Location Distribution
3.4.2 Players Biologic Medications for Psoriasis Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BIOLOGIC MEDICATIONS FOR PSORIASIS BY GEOGRAPHIC REGION
4.1 World Historic Biologic Medications for Psoriasis Market Size by Geographic Region (2019-2024)
4.1.1 Global Biologic Medications for Psoriasis Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Biologic Medications for Psoriasis Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Biologic Medications for Psoriasis Market Size by Country/Region (2019-2024)
4.2.1 Global Biologic Medications for Psoriasis Annual Sales by Country/Region (2019-2024)
4.2.2 Global Biologic Medications for Psoriasis Annual Revenue by Country/Region (2019-2024)
4.3 Americas Biologic Medications for Psoriasis Sales Growth
4.4 APAC Biologic Medications for Psoriasis Sales Growth
4.5 Europe Biologic Medications for Psoriasis Sales Growth
4.6 Middle East & Africa Biologic Medications for Psoriasis Sales Growth
5 AMERICAS
5.1 Americas Biologic Medications for Psoriasis Sales by Country
5.1.1 Americas Biologic Medications for Psoriasis Sales by Country (2019-2024)
5.1.2 Americas Biologic Medications for Psoriasis Revenue by Country (2019-2024)
5.2 Americas Biologic Medications for Psoriasis Sales by Type (2019-2024)
5.3 Americas Biologic Medications for Psoriasis Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biologic Medications for Psoriasis Sales by Region
6.1.1 APAC Biologic Medications for Psoriasis Sales by Region (2019-2024)
6.1.2 APAC Biologic Medications for Psoriasis Revenue by Region (2019-2024)
6.2 APAC Biologic Medications for Psoriasis Sales by Type (2019-2024)
6.3 APAC Biologic Medications for Psoriasis Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Biologic Medications for Psoriasis by Country
7.1.1 Europe Biologic Medications for Psoriasis Sales by Country (2019-2024)
7.1.2 Europe Biologic Medications for Psoriasis Revenue by Country (2019-2024)
7.2 Europe Biologic Medications for Psoriasis Sales by Type (2019-2024)
7.3 Europe Biologic Medications for Psoriasis Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biologic Medications for Psoriasis by Country
8.1.1 Middle East & Africa Biologic Medications for Psoriasis Sales by Country (2019-2024)
8.1.2 Middle East & Africa Biologic Medications for Psoriasis Revenue by Country (2019-2024)
8.2 Middle East & Africa Biologic Medications for Psoriasis Sales by Type (2019-2024)
8.3 Middle East & Africa Biologic Medications for Psoriasis Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Biologic Medications for Psoriasis
10.3 Manufacturing Process Analysis of Biologic Medications for Psoriasis
10.4 Industry Chain Structure of Biologic Medications for Psoriasis
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Biologic Medications for Psoriasis Distributors
11.3 Biologic Medications for Psoriasis Customer
12 WORLD FORECAST REVIEW FOR BIOLOGIC MEDICATIONS FOR PSORIASIS BY GEOGRAPHIC REGION
12.1 Global Biologic Medications for Psoriasis Market Size Forecast by Region
12.1.1 Global Biologic Medications for Psoriasis Forecast by Region (2025-2030)
12.1.2 Global Biologic Medications for Psoriasis Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Biologic Medications for Psoriasis Forecast by Type (2025-2030)
12.7 Global Biologic Medications for Psoriasis Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Bristol-Myers Squibb
13.1.1 Bristol-Myers Squibb Company Information
13.1.2 Bristol-Myers Squibb Biologic Medications for Psoriasis Product Portfolios and Specifications
13.1.3 Bristol-Myers Squibb Biologic Medications for Psoriasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Bristol-Myers Squibb Main Business Overview
13.1.5 Bristol-Myers Squibb Latest Developments
13.2 Amgen
13.2.1 Amgen Company Information
13.2.2 Amgen Biologic Medications for Psoriasis Product Portfolios and Specifications
13.2.3 Amgen Biologic Medications for Psoriasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Amgen Main Business Overview
13.2.5 Amgen Latest Developments
13.3 Tiefenbacher Pharmaceuticals
13.3.1 Tiefenbacher Pharmaceuticals Company Information
13.3.2 Tiefenbacher Pharmaceuticals Biologic Medications for Psoriasis Product Portfolios and Specifications
13.3.3 Tiefenbacher Pharmaceuticals Biologic Medications for Psoriasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Tiefenbacher Pharmaceuticals Main Business Overview
13.3.5 Tiefenbacher Pharmaceuticals Latest Developments
13.4 UCB
13.4.1 UCB Company Information
13.4.2 UCB Biologic Medications for Psoriasis Product Portfolios and Specifications
13.4.3 UCB Biologic Medications for Psoriasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 UCB Main Business Overview
13.4.5 UCB Latest Developments
13.5 Janssen Biotech
13.5.1 Janssen Biotech Company Information
13.5.2 Janssen Biotech Biologic Medications for Psoriasis Product Portfolios and Specifications
13.5.3 Janssen Biotech Biologic Medications for Psoriasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Janssen Biotech Main Business Overview
13.5.5 Janssen Biotech Latest Developments
13.6 Eli Lilly
13.6.1 Eli Lilly Company Information
13.6.2 Eli Lilly Biologic Medications for Psoriasis Product Portfolios and Specifications
13.6.3 Eli Lilly Biologic Medications for Psoriasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Eli Lilly Main Business Overview
13.6.5 Eli Lilly Latest Developments
13.7 AbbVie Biotechnology
13.7.1 AbbVie Biotechnology Company Information
13.7.2 AbbVie Biotechnology Biologic Medications for Psoriasis Product Portfolios and Specifications
13.7.3 AbbVie Biotechnology Biologic Medications for Psoriasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 AbbVie Biotechnology Main Business Overview
13.7.5 AbbVie Biotechnology Latest Developments
13.8 Dalian Yawei Pharmaceutical
13.8.1 Dalian Yawei Pharmaceutical Company Information
13.8.2 Dalian Yawei Pharmaceutical Biologic Medications for Psoriasis Product Portfolios and Specifications
13.8.3 Dalian Yawei Pharmaceutical Biologic Medications for Psoriasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Dalian Yawei Pharmaceutical Main Business Overview
13.8.5 Dalian Yawei Pharmaceutical Latest Developments
13.9 Novartis
13.9.1 Novartis Company Information
13.9.2 Novartis Biologic Medications for Psoriasis Product Portfolios and Specifications
13.9.3 Novartis Biologic Medications for Psoriasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Novartis Main Business Overview
13.9.5 Novartis Latest Developments
13.10 Ortho Dermatologics
13.10.1 Ortho Dermatologics Company Information
13.10.2 Ortho Dermatologics Biologic Medications for Psoriasis Product Portfolios and Specifications
13.10.3 Ortho Dermatologics Biologic Medications for Psoriasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Ortho Dermatologics Main Business Overview
13.10.5 Ortho Dermatologics Latest Developments
13.11 LEO Pharma
13.11.1 LEO Pharma Company Information
13.11.2 LEO Pharma Biologic Medications for Psoriasis Product Portfolios and Specifications
13.11.3 LEO Pharma Biologic Medications for Psoriasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 LEO Pharma Main Business Overview
13.11.5 LEO Pharma Latest Developments
13.12 Kyowa Kirin
13.12.1 Kyowa Kirin Company Information
13.12.2 Kyowa Kirin Biologic Medications for Psoriasis Product Portfolios and Specifications
13.12.3 Kyowa Kirin Biologic Medications for Psoriasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Kyowa Kirin Main Business Overview
13.12.5 Kyowa Kirin Latest Developments
13.13 Boehringer Ingelheim Pharmaceuticals
13.13.1 Boehringer Ingelheim Pharmaceuticals Company Information
13.13.2 Boehringer Ingelheim Pharmaceuticals Biologic Medications for Psoriasis Product Portfolios and Specifications
13.13.3 Boehringer Ingelheim Pharmaceuticals Biologic Medications for Psoriasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Boehringer Ingelheim Pharmaceuticals Main Business Overview
13.13.5 Boehringer Ingelheim Pharmaceuticals Latest Developments
13.14 Pfizer
13.14.1 Pfizer Company Information
13.14.2 Pfizer Biologic Medications for Psoriasis Product Portfolios and Specifications
13.14.3 Pfizer Biologic Medications for Psoriasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Pfizer Main Business Overview
13.14.5 Pfizer Latest Developments
13.15 Samsung Bioepis
13.15.1 Samsung Bioepis Company Information
13.15.2 Samsung Bioepis Biologic Medications for Psoriasis Product Portfolios and Specifications
13.15.3 Samsung Bioepis Biologic Medications for Psoriasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Samsung Bioepis Main Business Overview
13.15.5 Samsung Bioepis Latest Developments
13.16 Qilu Pharmaceutical
13.16.1 Qilu Pharmaceutical Company Information
13.16.2 Qilu Pharmaceutical Biologic Medications for Psoriasis Product Portfolios and Specifications
13.16.3 Qilu Pharmaceutical Biologic Medications for Psoriasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Qilu Pharmaceutical Main Business Overview
13.16.5 Qilu Pharmaceutical Latest Developments
13.17 Hanwha Chemical
13.17.1 Hanwha Chemical Company Information
13.17.2 Hanwha Chemical Biologic Medications for Psoriasis Product Portfolios and Specifications
13.17.3 Hanwha Chemical Biologic Medications for Psoriasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Hanwha Chemical Main Business Overview
13.17.5 Hanwha Chemical Latest Developments
13.18 China Medical System
13.18.1 China Medical System Company Information
13.18.2 China Medical System Biologic Medications for Psoriasis Product Portfolios and Specifications
13.18.3 China Medical System Biologic Medications for Psoriasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 China Medical System Main Business Overview
13.18.5 China Medical System Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Biologic Medications for Psoriasis Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Biologic Medications for Psoriasis Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players ofTNF-? Inhibitors
Table 4. Major Players of Interleukin Inhibitors
Table 5. Major Players ofTyrosine Kinase Inhibitors
Table 6. Major Players of Phosphodiesterase Inhibitors
Table 7. Major Players of Other
Table 8. Global Biologic Medications for Psoriasis Sales byType (2019-2024) & (K Units)
Table 9. Global Biologic Medications for Psoriasis Sales Market Share byType (2019-2024)
Table 10. Global Biologic Medications for Psoriasis Revenue byType (2019-2024) & ($ million)
Table 11. Global Biologic Medications for Psoriasis Revenue Market Share byType (2019-2024)
Table 12. Global Biologic Medications for Psoriasis Sale Price byType (2019-2024) & (US$/Unit)
Table 13. Global Biologic Medications for Psoriasis Sale by Application (2019-2024) & (K Units)
Table 14. Global Biologic Medications for Psoriasis Sale Market Share by Application (2019-2024)
Table 15. Global Biologic Medications for Psoriasis Revenue by Application (2019-2024) & ($ million)
Table 16. Global Biologic Medications for Psoriasis Revenue Market Share by Application (2019-2024)
Table 17. Global Biologic Medications for Psoriasis Sale Price by Application (2019-2024) & (US$/Unit)
Table 18. Global Biologic Medications for Psoriasis Sales by Company (2019-2024) & (K Units)
Table 19. Global Biologic Medications for Psoriasis Sales Market Share by Company (2019-2024)
Table 20. Global Biologic Medications for Psoriasis Revenue by Company (2019-2024) & ($ millions)
Table 21. Global Biologic Medications for Psoriasis Revenue Market Share by Company (2019-2024)
Table 22. Global Biologic Medications for Psoriasis Sale Price by Company (2019-2024) & (US$/Unit)
Table 23. Key Manufacturers Biologic Medications for Psoriasis Producing Area Distribution and Sales Area
Table 24. Players Biologic Medications for Psoriasis Products Offered
Table 25. Biologic Medications for Psoriasis Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Biologic Medications for Psoriasis Sales by Geographic Region (2019-2024) & (K Units)
Table 29. Global Biologic Medications for Psoriasis Sales Market Share Geographic Region (2019-2024)
Table 30. Global Biologic Medications for Psoriasis Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Biologic Medications for Psoriasis Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Biologic Medications for Psoriasis Sales by Country/Region (2019-2024) & (K Units)
Table 33. Global Biologic Medications for Psoriasis Sales Market Share by Country/Region (2019-2024)
Table 34. Global Biologic Medications for Psoriasis Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Biologic Medications for Psoriasis Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Biologic Medications for Psoriasis Sales by Country (2019-2024) & (K Units)
Table 37. Americas Biologic Medications for Psoriasis Sales Market Share by Country (2019-2024)
Table 38. Americas Biologic Medications for Psoriasis Revenue by Country (2019-2024) & ($ millions)
Table 39. Americas Biologic Medications for Psoriasis Sales byType (2019-2024) & (K Units)
Table 40. Americas Biologic Medications for Psoriasis Sales by Application (2019-2024) & (K Units)
Table 41. APAC Biologic Medications for Psoriasis Sales by Region (2019-2024) & (K Units)
Table 42. APAC Biologic Medications for Psoriasis Sales Market Share by Region (2019-2024)
Table 43. APAC Biologic Medications for Psoriasis Revenue by Region (2019-2024) & ($ millions)
Table 44. APAC Biologic Medications for Psoriasis Sales byType (2019-2024) & (K Units)
Table 45. APAC Biologic Medications for Psoriasis Sales by Application (2019-2024) & (K Units)
Table 46. Europe Biologic Medications for Psoriasis Sales by Country (2019-2024) & (K Units)
Table 47. Europe Biologic Medications for Psoriasis Revenue by Country (2019-2024) & ($ millions)
Table 48. Europe Biologic Medications for Psoriasis Sales byType (2019-2024) & (K Units)
Table 49. Europe Biologic Medications for Psoriasis Sales by Application (2019-2024) & (K Units)
Table 50. Middle East & Africa Biologic Medications for Psoriasis Sales by Country (2019-2024) & (K Units)
Table 51. Middle East & Africa Biologic Medications for Psoriasis Revenue Market Share by Country (2019-2024)
Table 52. Middle East & Africa Biologic Medications for Psoriasis Sales byType (2019-2024) & (K Units)
Table 53. Middle East & Africa Biologic Medications for Psoriasis Sales by Application (2019-2024) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Biologic Medications for Psoriasis
Table 55. Key Market Challenges & Risks of Biologic Medications for Psoriasis
Table 56. Key IndustryTrends of Biologic Medications for Psoriasis
Table 57. Biologic Medications for Psoriasis Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Biologic Medications for Psoriasis Distributors List
Table 60. Biologic Medications for Psoriasis Customer List
Table 61. Global Biologic Medications for Psoriasis SalesForecast by Region (2025-2030) & (K Units)
Table 62. Global Biologic Medications for Psoriasis RevenueForecast by Region (2025-2030) & ($ millions)
Table 63. Americas Biologic Medications for Psoriasis SalesForecast by Country (2025-2030) & (K Units)
Table 64. Americas Biologic Medications for Psoriasis Annual RevenueForecast by Country (2025-2030) & ($ millions)
Table 65. APAC Biologic Medications for Psoriasis SalesForecast by Region (2025-2030) & (K Units)
Table 66. APAC Biologic Medications for Psoriasis Annual RevenueForecast by Region (2025-2030) & ($ millions)
Table 67. Europe Biologic Medications for Psoriasis SalesForecast by Country (2025-2030) & (K Units)
Table 68. Europe Biologic Medications for Psoriasis RevenueForecast by Country (2025-2030) & ($ millions)
Table 69. Middle East & Africa Biologic Medications for Psoriasis SalesForecast by Country (2025-2030) & (K Units)
Table 70. Middle East & Africa Biologic Medications for Psoriasis RevenueForecast by Country (2025-2030) & ($ millions)
Table 71. Global Biologic Medications for Psoriasis SalesForecast byType (2025-2030) & (K Units)
Table 72. Global Biologic Medications for Psoriasis RevenueForecast byType (2025-2030) & ($ millions)
Table 73. Global Biologic Medications for Psoriasis SalesForecast by Application (2025-2030) & (K Units)
Table 74. Global Biologic Medications for Psoriasis RevenueForecast by Application (2025-2030) & ($ millions)
Table 75. Bristol-Myers Squibb Basic Information, Biologic Medications for Psoriasis Manufacturing Base, Sales Area and Its Competitors
Table 76. Bristol-Myers Squibb Biologic Medications for Psoriasis Product Portfolios and Specifications
Table 77. Bristol-Myers Squibb Biologic Medications for Psoriasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Bristol-Myers Squibb Main Business
Table 79. Bristol-Myers Squibb Latest Developments
Table 80. Amgen Basic Information, Biologic Medications for Psoriasis Manufacturing Base, Sales Area and Its Competitors
Table 81. Amgen Biologic Medications for Psoriasis Product Portfolios and Specifications
Table 82. Amgen Biologic Medications for Psoriasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Amgen Main Business
Table 84. Amgen Latest Developments
Table 85.Tiefenbacher Pharmaceuticals Basic Information, Biologic Medications for Psoriasis Manufacturing Base, Sales Area and Its Competitors
Table 86.Tiefenbacher Pharmaceuticals Biologic Medications for Psoriasis Product Portfolios and Specifications
Table 87.Tiefenbacher Pharmaceuticals Biologic Medications for Psoriasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88.Tiefenbacher Pharmaceuticals Main Business
Table 89.Tiefenbacher Pharmaceuticals Latest Developments
Table 90. UCB Basic Information, Biologic Medications for Psoriasis Manufacturing Base, Sales Area and Its Competitors
Table 91. UCB Biologic Medications for Psoriasis Product Portfolios and Specifications
Table 92. UCB Biologic Medications for Psoriasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. UCB Main Business
Table 94. UCB Latest Developments
Table 95. Janssen Biotech Basic Information, Biologic Medications for Psoriasis Manufacturing Base, Sales Area and Its Competitors
Table 96. Janssen Biotech Biologic Medications for Psoriasis Product Portfolios and Specifications
Table 97. Janssen Biotech Biologic Medications for Psoriasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Janssen Biotech Main Business
Table 99. Janssen Biotech Latest Developments
Table 100. Eli Lilly Basic Information, Biologic Medications for Psoriasis Manufacturing Base, Sales Area and Its Competitors
Table 101. Eli Lilly Biologic Medications for Psoriasis Product Portfolios and Specifications
Table 102. Eli Lilly Biologic Medications for Psoriasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Eli Lilly Main Business
Table 104. Eli Lilly Latest Developments
Table 105. AbbVie Biotechnology Basic Information, Biologic Medications for Psoriasis Manufacturing Base, Sales Area and Its Competitors
Table 106. AbbVie Biotechnology Biologic Medications for Psoriasis Product Portfolios and Specifications
Table 107. AbbVie Biotechnology Biologic Medications for Psoriasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. AbbVie Biotechnology Main Business
Table 109. AbbVie Biotechnology Latest Developments
Table 110. Dalian Yawei Pharmaceutical Basic Information, Biologic Medications for Psoriasis Manufacturing Base, Sales Area and Its Competitors
Table 111. Dalian Yawei Pharmaceutical Biologic Medications for Psoriasis Product Portfolios and Specifications
Table 112. Dalian Yawei Pharmaceutical Biologic Medications for Psoriasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Dalian Yawei Pharmaceutical Main Business
Table 114. Dalian Yawei Pharmaceutical Latest Developments
Table 115. Novartis Basic Information, Biologic Medications for Psoriasis Manufacturing Base, Sales Area and Its Competitors
Table 116. Novartis Biologic Medications for Psoriasis Product Portfolios and Specifications
Table 117. Novartis Biologic Medications for Psoriasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Novartis Main Business
Table 119. Novartis Latest Developments
Table 120. Ortho Dermatologics Basic Information, Biologic Medications for Psoriasis Manufacturing Base, Sales Area and Its Competitors
Table 121. Ortho Dermatologics Biologic Medications for Psoriasis Product Portfolios and Specifications
Table 122. Ortho Dermatologics Biologic Medications for Psoriasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Ortho Dermatologics Main Business
Table 124. Ortho Dermatologics Latest Developments
Table 125. LEO Pharma Basic Information, Biologic Medications for Psoriasis Manufacturing Base, Sales Area and Its Competitors
Table 126. LEO Pharma Biologic Medications for Psoriasis Product Portfolios and Specifications
Table 127. LEO Pharma Biologic Medications for Psoriasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. LEO Pharma Main Business
Table 129. LEO Pharma Latest Developments
Table 130. Kyowa Kirin Basic Information, Biologic Medications for Psoriasis Manufacturing Base, Sales Area and Its Competitors
Table 131. Kyowa Kirin Biologic Medications for Psoriasis Product Portfolios and Specifications
Table 132. Kyowa Kirin Biologic Medications for Psoriasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Kyowa Kirin Main Business
Table 134. Kyowa Kirin Latest Developments
Table 135. Boehringer Ingelheim Pharmaceuticals Basic Information, Biologic Medications for Psoriasis Manufacturing Base, Sales Area and Its Competitors
Table 136. Boehringer Ingelheim Pharmaceuticals Biologic Medications for Psoriasis Product Portfolios and Specifications
Table 137. Boehringer Ingelheim Pharmaceuticals Biologic Medications for Psoriasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Boehringer Ingelheim Pharmaceuticals Main Business
Table 139. Boehringer Ingelheim Pharmaceuticals Latest Developments
Table 140. Pfizer Basic Information, Biologic Medications for Psoriasis Manufacturing Base, Sales Area and Its Competitors
Table 141. Pfizer Biologic Medications for Psoriasis Product Portfolios and Specifications
Table 142. Pfizer Biologic Medications for Psoriasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Pfizer Main Business
Table 144. Pfizer Latest Developments
Table 145. Samsung Bioepis Basic Information, Biologic Medications for Psoriasis Manufacturing Base, Sales Area and Its Competitors
Table 146. Samsung Bioepis Biologic Medications for Psoriasis Product Portfolios and Specifications
Table 147. Samsung Bioepis Biologic Medications for Psoriasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Samsung Bioepis Main Business
Table 149. Samsung Bioepis Latest Developments
Table 150. Qilu Pharmaceutical Basic Information, Biologic Medications for Psoriasis Manufacturing Base, Sales Area and Its Competitors
Table 151. Qilu Pharmaceutical Biologic Medications for Psoriasis Product Portfolios and Specifications
Table 152. Qilu Pharmaceutical Biologic Medications for Psoriasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Qilu Pharmaceutical Main Business
Table 154. Qilu Pharmaceutical Latest Developments
Table 155. Hanwha Chemical Basic Information, Biologic Medications for Psoriasis Manufacturing Base, Sales Area and Its Competitors
Table 156. Hanwha Chemical Biologic Medications for Psoriasis Product Portfolios and Specifications
Table 157. Hanwha Chemical Biologic Medications for Psoriasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. Hanwha Chemical Main Business
Table 159. Hanwha Chemical Latest Developments
Table 160. China Medical System Basic Information, Biologic Medications for Psoriasis Manufacturing Base, Sales Area and Its Competitors
Table 161. China Medical System Biologic Medications for Psoriasis Product Portfolios and Specifications
Table 162. China Medical System Biologic Medications for Psoriasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 163. China Medical System Main Business
Table 164. China Medical System Latest Developments
LIST OFFIGURES
Figure 1. Picture of Biologic Medications for Psoriasis
Figure 2. Biologic Medications for Psoriasis Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biologic Medications for Psoriasis Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Biologic Medications for Psoriasis Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Biologic Medications for Psoriasis Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Biologic Medications for Psoriasis Sales Market Share by Country/Region (2023)
Figure 10. Biologic Medications for Psoriasis Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture ofTNF-? Inhibitors
Figure 12. Product Picture of Interleukin Inhibitors
Figure 13. Product Picture ofTyrosine Kinase Inhibitors
Figure 14. Product Picture of Phosphodiesterase Inhibitors
Figure 15. Product Picture of Other
Figure 16. Global Biologic Medications for Psoriasis Sales Market Share byType in 2023
Figure 17. Global Biologic Medications for Psoriasis Revenue Market Share byType (2019-2024)
Figure 18. Biologic Medications for Psoriasis Consumed in Hospital and Clinic
Figure 19. Global Biologic Medications for Psoriasis Market: Hospital and Clinic (2019-2024) & (K Units)
Figure 20. Biologic Medications for Psoriasis Consumed in Retail Pharmacies
Figure 21. Global Biologic Medications for Psoriasis Market: Retail Pharmacies (2019-2024) & (K Units)
Figure 22. Biologic Medications for Psoriasis Consumed in Other
Figure 23. Global Biologic Medications for Psoriasis Market: Other (2019-2024) & (K Units)
Figure 24. Global Biologic Medications for Psoriasis Sale Market Share by Application (2023)
Figure 25. Global Biologic Medications for Psoriasis Revenue Market Share by Application in 2023
Figure 26. Biologic Medications for Psoriasis Sales by Company in 2023 (K Units)
Figure 27. Global Biologic Medications for Psoriasis Sales Market Share by Company in 2023
Figure 28. Biologic Medications for Psoriasis Revenue by Company in 2023 ($ millions)
Figure 29. Global Biologic Medications for Psoriasis Revenue Market Share by Company in 2023
Figure 30. Global Biologic Medications for Psoriasis Sales Market Share by Geographic Region (2019-2024)
Figure 31. Global Biologic Medications for Psoriasis Revenue Market Share by Geographic Region in 2023
Figure 32. Americas Biologic Medications for Psoriasis Sales 2019-2024 (K Units)
Figure 33. Americas Biologic Medications for Psoriasis Revenue 2019-2024 ($ millions)
Figure 34. APAC Biologic Medications for Psoriasis Sales 2019-2024 (K Units)
Figure 35. APAC Biologic Medications for Psoriasis Revenue 2019-2024 ($ millions)
Figure 36. Europe Biologic Medications for Psoriasis Sales 2019-2024 (K Units)
Figure 37. Europe Biologic Medications for Psoriasis Revenue 2019-2024 ($ millions)
Figure 38. Middle East & Africa Biologic Medications for Psoriasis Sales 2019-2024 (K Units)
Figure 39. Middle East & Africa Biologic Medications for Psoriasis Revenue 2019-2024 ($ millions)
Figure 40. Americas Biologic Medications for Psoriasis Sales Market Share by Country in 2023
Figure 41. Americas Biologic Medications for Psoriasis Revenue Market Share by Country (2019-2024)
Figure 42. Americas Biologic Medications for Psoriasis Sales Market Share byType (2019-2024)
Figure 43. Americas Biologic Medications for Psoriasis Sales Market Share by Application (2019-2024)
Figure 44. United States Biologic Medications for Psoriasis Revenue Growth 2019-2024 ($ millions)
Figure 45. Canada Biologic Medications for Psoriasis Revenue Growth 2019-2024 ($ millions)
Figure 46. Mexico Biologic Medications for Psoriasis Revenue Growth 2019-2024 ($ millions)
Figure 47. Brazil Biologic Medications for Psoriasis Revenue Growth 2019-2024 ($ millions)
Figure 48. APAC Biologic Medications for Psoriasis Sales Market Share by Region in 2023
Figure 49. APAC Biologic Medications for Psoriasis Revenue Market Share by Region (2019-2024)
Figure 50. APAC Biologic Medications for Psoriasis Sales Market Share byType (2019-2024)
Figure 51. APAC Biologic Medications for Psoriasis Sales Market Share by Application (2019-2024)
Figure 52. China Biologic Medications for Psoriasis Revenue Growth 2019-2024 ($ millions)
Figure 53. Japan Biologic Medications for Psoriasis Revenue Growth 2019-2024 ($ millions)
Figure 54. South Korea Biologic Medications for Psoriasis Revenue Growth 2019-2024 ($ millions)
Figure 55. Southeast Asia Biologic Medications for Psoriasis Revenue Growth 2019-2024 ($ millions)
Figure 56. India Biologic Medications for Psoriasis Revenue Growth 2019-2024 ($ millions)
Figure 57. Australia Biologic Medications for Psoriasis Revenue Growth 2019-2024 ($ millions)
Figure 58. ChinaTaiwan Biologic Medications for Psoriasis Revenue Growth 2019-2024 ($ millions)
Figure 59. Europe Biologic Medications for Psoriasis Sales Market Share by Country in 2023
Figure 60. Europe Biologic Medications for Psoriasis Revenue Market Share by Country (2019-2024)
Figure 61. Europe Biologic Medications for Psoriasis Sales Market Share byType (2019-2024)
Figure 62. Europe Biologic Medications for Psoriasis Sales Market Share by Application (2019-2024)
Figure 63. Germany Biologic Medications for Psoriasis Revenue Growth 2019-2024 ($ millions)
Figure 64.France Biologic Medications for Psoriasis Revenue Growth 2019-2024 ($ millions)
Figure 65. UK Biologic Medications for Psoriasis Revenue Growth 2019-2024 ($ millions)
Figure 66. Italy Biologic Medications for Psoriasis Revenue Growth 2019-2024 ($ millions)
Figure 67. Russia Biologic Medications for Psoriasis Revenue Growth 2019-2024 ($ millions)
Figure 68. Middle East & Africa Biologic Medications for Psoriasis Sales Market Share by Country (2019-2024)
Figure 69. Middle East & Africa Biologic Medications for Psoriasis Sales Market Share byType (2019-2024)
Figure 70. Middle East & Africa Biologic Medications for Psoriasis Sales Market Share by Application (2019-2024)
Figure 71. Egypt Biologic Medications for Psoriasis Revenue Growth 2019-2024 ($ millions)
Figure 72. South Africa Biologic Medications for Psoriasis Revenue Growth 2019-2024 ($ millions)
Figure 73. Israel Biologic Medications for Psoriasis Revenue Growth 2019-2024 ($ millions)
Figure 74.Turkey Biologic Medications for Psoriasis Revenue Growth 2019-2024 ($ millions)
Figure 75. GCC Countries Biologic Medications for Psoriasis Revenue Growth 2019-2024 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Biologic Medications for Psoriasis in 2023
Figure 77. Manufacturing Process Analysis of Biologic Medications for Psoriasis
Figure 78. Industry Chain Structure of Biologic Medications for Psoriasis
Figure 79. Channels of Distribution
Figure 80. Global Biologic Medications for Psoriasis Sales MarketForecast by Region (2025-2030)
Figure 81. Global Biologic Medications for Psoriasis Revenue Market ShareForecast by Region (2025-2030)
Figure 82. Global Biologic Medications for Psoriasis Sales Market ShareForecast byType (2025-2030)
Figure 83. Global Biologic Medications for Psoriasis Revenue Market ShareForecast byType (2025-2030)
Figure 84. Global Biologic Medications for Psoriasis Sales Market ShareForecast by Application (2025-2030)
Figure 85. Global Biologic Medications for Psoriasis Revenue Market ShareForecast by Application (2025-2030)
